Diverse mechanisms for cell attachment to platelet thrombospondin.
Adams, J C, and J Lawler. 1993. “Diverse Mechanisms for Cell Attachment to Platelet Thrombospondin.”. Journal of Cell Science 104 ( Pt 4): 1061-71.
Search
Search results
207 results found
Extracellular matrix: the thrombospondin family.
Adams, J, and J Lawler. 1993. “Extracellular Matrix: The Thrombospondin Family.”. Current Biology : CB 3 (3): 188-90.
Partial ankyrin and spectrin deficiency in severe, atypical hereditary spherocytosis.
Coetzer, T L, J Lawler, S C Liu, J T Prchal, R J Gualtieri, M C Brain, J Dacie V, and J Palek. 1988. “Partial Ankyrin and Spectrin Deficiency in Severe, Atypical Hereditary Spherocytosis.”. The New England Journal of Medicine 318 (4): 230-4.
Thrombin and chymotrypsin interactions with thrombospondin.
Lawler, J, J E Connolly, P Ferro, and L H Derick. 1986. “Thrombin and Chymotrypsin Interactions With Thrombospondin.”. Annals of the New York Academy of Sciences 485: 273-87.
The structure of human platelet thrombospondin.
Lawler, J, L H Derick, J E Connolly, J H Chen, and F C Chao. 1985. “The Structure of Human Platelet Thrombospondin.”. The Journal of Biological Chemistry 260 (6): 3762-72.
Observation of a high molecular weight platelet protein released by thrombin.
Lawler, J W, F C Chao, and P H Fang. 1977. “Observation of a High Molecular Weight Platelet Protein Released by Thrombin.”. Thrombosis and Haemostasis 37 (2): 355-7.
Aggregation of platelets and inert particles induced by thrombin.
Chao, F C, J L Tullis, G S Conneely, and J W Lawler. 1976. “Aggregation of Platelets and Inert Particles Induced by Thrombin.”. Thrombosis and Haemostasis 35 (3): 717-36.
Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer.
Russell, Samantha, Mark Duquette, Joyce Liu, Ronny Drapkin, Jack Lawler, and Jim Petrik. 2015. “Combined Therapy With Thrombospondin-1 Type I Repeats (3TSR) and Chemotherapy Induces Regression and Significantly Improves Survival in a Preclinical Model of Advanced Stage Epithelial Ovarian Cancer.”. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 29 (2): 576-88.
Masking epistasis between MYC and TGF-β pathways in antiangiogenesis-mediated colon cancer suppression.
Dews, Michael, Grace S Tan, Stacy Hultine, Pichai Raman, Jaewoo Choi, Elizabeth K Duperret, Jack Lawler, Adam Bass, and Andrei Thomas-Tikhonenko. 2014. “Masking Epistasis Between MYC and TGF-β Pathways in Antiangiogenesis-Mediated Colon Cancer Suppression.”. Journal of the National Cancer Institute 106 (4): dju043.
SCF(β-TRCP) suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2.
Shaik, Shavali, Carmelo Nucera, Hiroyuki Inuzuka, Daming Gao, Maija Garnaas, Gregory Frechette, Lauren Harris, et al. 2012. “SCF(β-TRCP) Suppresses Angiogenesis and Thyroid Cancer Cell Migration by Promoting Ubiquitination and Destruction of VEGF Receptor 2.”. The Journal of Experimental Medicine 209 (7): 1289-307.